Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L De Backer

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Clinical Pharmacology|August 22, 2000
Oral vasoactive medication in intermittent claudication: utile or futile?T L De Backer, R H Vander Stichele, H H Warie, et al.
Age and Ageing|March 19, 2023
Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort studyMaxim Grymonprez, Mirko Petrovic, Tine L De Backer, et al.
Brain & Spine|January 19, 2026
Temporal muscle measurements as predictor for outcome in a cohort of IDH-wildtype glioblastoma patientsH Pinson, C De Rudder, L De Backer, et al.
Frontiers in Cardiovascular Medicine|October 17, 2022
Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort studyMaxim Grymonprez, Andreas Capiau, Stephane Steurbaut, et al.
Journal of Human Hypertension|August 5, 2000
Cardiac involvement in pheochromocytomaT L De Backer, M L De Buyzere, Y Taeymans, et al.
British Journal of Clinical Pharmacology|November 2, 2022
Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort studyMaxim Grymonprez, Tine L De Backer, Andreas Capiau, et al.
Tijdschrift Voor Psychiatrie|February 23, 2021
A T F Beekman, M H J Hillegers, L De Backer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 4, 2023
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort studyMaxim Grymonprez, Laura Carnoy, Andreas Capiau, et al.
Acta Cardiologica|April 24, 1999
Primary pulmonary hypertension with fatal outcome in a young woman and review of the literatureT L De Backer, M L De Buyzere, C R De Potter, et al.
Journal of Clinical Medicine|August 14, 2025
Practical Comprehensive Approach to Current Atrial Fibrillation Challenges: Insights from an Expert PanelCarlos Escobar, Miguel Camafort, Elena Fortuny, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Clinical Pharmacology|August 22, 2000
Oral vasoactive medication in intermittent claudication: utile or futile?T L De Backer, R H Vander Stichele, H H Warie, et al.
Age and Ageing|March 19, 2023
Comparing the risk of dementia in subjects with atrial fibrillation using non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists: a Belgian nationwide cohort studyMaxim Grymonprez, Mirko Petrovic, Tine L De Backer, et al.
Brain & Spine|January 19, 2026
Temporal muscle measurements as predictor for outcome in a cohort of IDH-wildtype glioblastoma patientsH Pinson, C De Rudder, L De Backer, et al.
Frontiers in Cardiovascular Medicine|October 17, 2022
Adherence and persistence to oral anticoagulants in patients with atrial fibrillation: A Belgian nationwide cohort studyMaxim Grymonprez, Andreas Capiau, Stephane Steurbaut, et al.
Journal of Human Hypertension|August 5, 2000
Cardiac involvement in pheochromocytomaT L De Backer, M L De Buyzere, Y Taeymans, et al.
British Journal of Clinical Pharmacology|November 2, 2022
Trends in oral anticoagulant use in patients with atrial fibrillation in Belgium from 2013 to 2019: A nationwide cohort studyMaxim Grymonprez, Tine L De Backer, Andreas Capiau, et al.
Tijdschrift Voor Psychiatrie|February 23, 2021
A T F Beekman, M H J Hillegers, L De Backer, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 4, 2023
Impact of P-glycoprotein and CYP3A4-interacting drugs on clinical outcomes in patients with atrial fibrillation using non-vitamin K antagonist oral anticoagulants: a nationwide cohort studyMaxim Grymonprez, Laura Carnoy, Andreas Capiau, et al.
Acta Cardiologica|April 24, 1999
Primary pulmonary hypertension with fatal outcome in a young woman and review of the literatureT L De Backer, M L De Buyzere, C R De Potter, et al.
Journal of Clinical Medicine|August 14, 2025
Practical Comprehensive Approach to Current Atrial Fibrillation Challenges: Insights from an Expert PanelCarlos Escobar, Miguel Camafort, Elena Fortuny, et al.
Pageof 4